Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase I Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients with Metastatic Castration Resistant Prostate Cancer
A Phase I Dose Escalation and Expanded Cohort Study of Pf-06821497 in the Treatment of Adult Patients with Relapsed/Refractory Small Cell Lung Cancer SCLC, Castration Resistant Prostate Cancer CRPC and Follicular Lymphoma FL
Measuring Surgical Recovery After Radical Cystectomy
Pilot Trial of Ultra-Hypofractionated Radiation in Early Prostate Cancer
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT03486821
Principal Investigator:
Xinglei Shen
PREcision DIagnostics in Prostate Cancer Treatment PREDICT
Study Type: Treatment
Phase: II
NCTID: NCT06632977
Principal Investigator:
Elizabeth Wulff-Burchfield
A Phase III, Multi-center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Men with Biochemical Recurrence of Prostate Cancer
Pilot of Osanetant to Reduce Testosterone in Men with Adenocarcinoma of the Prostate PORT-MAP
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT05607342
Principal Investigator:
William Parker
Phase III Randomized Trial of Standard Systemic Therapy SST versus Standard Systemic Therapy Plus Definitive Treatment Surgery or Radiation of the Primary Tumor in Metastatic Prostate Cancer
A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician?s Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer EvoPAR-Prostate01
Study Type: Treatment
Phase: III
NCTID: NCT06120491
Principal Investigator:
Elizabeth Wulff-Burchfield